Samsung Pharm Net Asset Quality Index
Samsung Pharm net asset quality index. Samsung Pharm (001360) has a Net Asset Quality Index of 80.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩224.14 Billion minus total liabilities of ₩44.04 Billion yields net assets of ₩180.09 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check cash flow quality index of Samsung Pharm to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Samsung Pharm (2012–2024)
Net asset quality index of Samsung Pharm from 2012 to 2024. This chart shows how Samsung Pharm's Net Asset Quality Index has evolved across 12 annual periods from 2012 to 2024. As of September 2025, the index stands at 80.4%, representing net assets of ₩180.09 Billion against total assets of ₩224.14 Billion KRW. See 001360 net asset value for net asset value and shareholders' equity analysis.
Samsung Pharm Net Asset Quality Index by Year (2012–2024)
Samsung Pharm net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for Samsung Pharm from 2012 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 001360 market cap.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 82.4% | ₩105.86 Billion | ₩128.45 Billion | ₩22.60 Billion | ▼ -0.6 pp |
| 2023 | 83.0% | ₩77.58 Billion | ₩93.48 Billion | ₩15.89 Billion | ▼ -4.0 pp |
| 2022 | 87.0% | ₩102.59 Billion | ₩117.91 Billion | ₩15.32 Billion | ▼ -0.5 pp |
| 2021 | 87.5% | ₩127.27 Billion | ₩145.46 Billion | ₩18.19 Billion | ▲ +19.3 pp |
| 2020 | 68.2% | ₩121.92 Billion | ₩178.73 Billion | ₩56.81 Billion | ▼ -16.5 pp |
| 2019 | 84.7% | ₩142.83 Billion | ₩168.53 Billion | ₩25.70 Billion | ▲ +2.8 pp |
| 2018 | 82.0% | ₩131.66 Billion | ₩160.65 Billion | ₩28.98 Billion | ▲ +21.1 pp |
| 2017 | 60.9% | ₩93.87 Billion | ₩154.19 Billion | ₩60.33 Billion | ▲ +1.3 pp |
| 2016 | 59.6% | ₩82.38 Billion | ₩138.28 Billion | ₩55.91 Billion | ▲ +24.1 pp |
| 2015 | 35.5% | ₩46.24 Billion | ₩130.22 Billion | ₩83.98 Billion | ▼ -5.1 pp |
| 2014 | 40.6% | ₩23.29 Billion | ₩57.41 Billion | ₩34.12 Billion | ▲ +6.9 pp |
| 2012 | 33.7% | ₩34.71 Billion | ₩103.02 Billion | ₩68.31 Billion | — |